PROMOTION OF CELL SURVIVAL BY ADENOVIRUS E1B 19K PROTEIN
PROMOTION OF CELL SURVIVAL BY ADENOVIRUS E1B 19K PROTEIN
批准号:
2088569
负责人:
GOVINDASWAMY CHINNADURAI
金额:
$17.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1998-08-31
关键词:
Adenoviridae apoptosis biological signal transduction calcium binding protein calcium flux cell free system cell transformation gene expression guanine nucleotide binding protein host organism interaction immunofluorescence technique immunoprecipitation laboratory mouse laboratory rat molecular cloning mutant necrosis oncoproteins phosphodiesterases protein purification protein structure function tissue /cell culture transfection virus DNA virus protein
中文摘要
受调控的细胞死亡是消除特定基因的重要过程
多细胞生物中的细胞在正常发育和
动态平衡。失控的细胞死亡可导致退行性疾病
例如阿尔茨海默氏症、帕金森氏症和艾滋病。对细胞的抑制
死亡也可能导致肿瘤形成和对化疗的抗药性。
治疗。人腺病毒E1B19kD蛋白是一种
一类与细胞抑制有关的蛋白质的重要成员
死亡。它促进了感染了腺病毒或
暴露在几种外部细胞死亡(凋亡)诱导刺激下。这个
19kD蛋白在功能上与Bc1-2原癌蛋白相似,
Epstein-Barr病毒BHRF1蛋白。出现了19kD和Bcl2蛋白
共享抑制细胞死亡所必需的共同序列基序。
我们已经鉴定并克隆了四种与之相互作用的细胞蛋白
19 kD(19-kD相互作用蛋白,Nip1至4)和Bc1-2蛋白
通过这些同源序列基序。为了阐明共同之处
19kD和Bc1-2蛋白抑制细胞死亡的机制
建议从功能上描述不同的国家行动方案。这些因素的作用
不同细胞因子诱导的细胞死亡中的细胞蛋白
机制将使用多个细胞死亡/存活分析来检验。
这些蛋白的内源性表达和亚细胞定位
本课程将研究对各种细胞死亡刺激的反应。
其中一些细胞蛋白含有耐人寻味的序列同源性。
Nip1与某些特定的催化结构域有有限的同源性
哺乳动物的磷酸二酯酶。Nip2与(GTPase-)有同源性
刺激蛋白RhoGAP。Nip3定位于线粒体。Nip2
和Nip4含有可能的钙结合基序。这些蛋白质将是
特征是阐明它们在信号转导和钙离子中的作用
动员。由于腺病毒诱导的细胞死亡效应分子
感染情况尚不清楚,我们建议使用无细胞体外细胞死亡
识别和克隆这种效应器的系统(S)。自停用
19kD和Bc1-2蛋白的促存活活性
有利的是,我们建议探索使用突变体的可能性
作为显性负抑制因子的生存区域存在缺陷。
类似地,与生存结构域相对应的多肽也将
被检测为19kD和Bc1-2蛋白的竞争性抑制物。因此,
我们的建议可能解释19kD和Bc1-2
蛋白质抑制细胞死亡,也揭示了干扰策略
他们的活动。
英文摘要
Regulated cell death is an important process for elimination of specific
cells in multicellular organisms during normal development and
homeostasis. Deregulated cell death can lead to degenerative diseases
such as Alzheimer's and Parkinson's disease and AIDS. Inhibition of cell
death can also lead to oncogenesis and resistance to chemotherapeutic
treatments. The E1B 19 kD protein of human adenovirus (Ad) is an
important member of a class of proteins involved in suppression of cell
death. It promotes the survival of cells infected with adenovirus or
exposed to several external cell death (apoptosis)-inducing stimuli. The
19 kD protein is functionally similar to the Bc1-2 protooncoprotein and
the Epstein-Barr virus BHRF1 protein. The 19 kD and Bcl-2 proteins appear
to share common sequence motifs essential for inhibition of cell death.
We have identified and cloned four cellular proteins that interact with
the 19 kD (19-kD-interacting proteins, Nip1 to 4) and the Bc1-2 proteins
through these homologous sequence motifs. To elucidate the common
mechanism of cell death inhibition by the 19 kD and Bc1-2 proteins, we
propose to functionally characterize the various Nips. The role of these
cellular proteins in regulating cell death induced by different
mechanisms will be examined using multiple cell death/survival assays.
Endogenous expression and subcellular localization of these proteins in
response to exposure to various cell death stimuli will be examined.
Some of these cellular proteins contain intriguing sequence homologies.
Nip1 shares limited homology with the catalytic domain of certain
mammalian phosphodiesterases. Nip2 shares homology with the (GTPase-
stimulating protein RhoGAP. Nip3 is localized in the mitochondria. Nip2
and Nip4 contain putative Ca2+ -binding motifs. These proteins will be
characterized to elucidate their role in signal transduction and calcium
mobilization. Since the cell death effectors induced by adenovirus
infection is not known, we propose to use a cell free in vitro cell death
system to identify and clone such effector(s). Since inactivation of
survival-promoting activities of the 19 kD and Bc1-2 proteins would be
advantageous, we propose to explore the possibility of using mutants
defective in the survival domains as dominant negative inhibitors.
Similarly, peptides corresponding to the survival domains will also be
examined as competitive inhibitors of the 19 kD and Bc1-2 proteins. Thus,
our proposal may illuminate the mechanism by which the 19 kD and Bc1-2
proteins suppress cell death and also reveal strategies to interfere with
their activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BH3-only protein BNIP3 in tumor progression
-
批准号:6957117
-
项目类别:
-
资助金额:$12.64万
-
财政年份:2005
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
BH3-only protein BNIP3 in tumor progression
-
批准号:7140163
-
项目类别:
-
资助金额:$12.34万
-
财政年份:2005
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Modulation of Oncogenesis by E1A--Role of CtBP and CtIP
-
批准号:6324435
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Modulation of Oncogenesis by E1A--Role of CtBP and CtIP
-
批准号:6710037
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Modulation of Oncogenesis by E1A--Role of CtBP and CtIP
-
批准号:6514350
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
E1A-CtBP interactions in oncogenic transformations
-
批准号:7898951
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
E1A-CtBP interactions in oncogenic transformations
-
批准号:7668342
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Modulation of Oncogenesis by E1A--Role of CtBP and CtIP
-
批准号:6871359
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
E1A-CtBP interactions in oncogenic transformations
-
批准号:7499104
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
E1A-CtBP interactions in oncogenic transformations
-
批准号:8104098
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Modulation of Oncogenesis by E1A--Role of CtBP and CtIP
-
批准号:6633611
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2001
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
APOPTOSIS REGULATION BY VIRAL AND CELLULAR PROTEINS
-
批准号:6172640
-
项目类别:
-
资助金额:$27.58万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
APOPTOSIS REGULATION BY VIRAL AND CELLULAR PROTEINS
-
批准号:2907616
-
项目类别:
-
资助金额:$23.52万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Apoptosis Regulation by Adenovirus and Cellular Genes
-
批准号:8130173
-
项目类别:
-
资助金额:$28.8万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Apoptosis Regulation by Adenovirus and Cellular Genes
-
批准号:8657981
-
项目类别:
-
资助金额:$27.94万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
APOPTOSIS REGULATION BY VIRAL AND CELLULAR PROTEINS
-
批准号:6375655
-
项目类别:
-
资助金额:$28.2万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
E1A-CtBP interactions in oncogenic transformations
-
批准号:7383289
-
项目类别:
-
资助金额:$27.93万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Apoptosis Regulation by Adenovirus and Cellular Genes
-
批准号:7253239
-
项目类别:
-
资助金额:$28.23万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Apoptosis Regulation by Adenovirus and Cellular Genes
-
批准号:7449764
-
项目类别:
-
资助金额:$28.23万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
Apoptosis Regulation by Adenovirus and Cellular Genes
-
批准号:6953596
-
项目类别:
-
资助金额:$29.77万
-
财政年份:1999
-
负责人:GOVINDASWAMY CHINNADURAI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: